Clinical research saw widespread disruption as sponsors paused their studies in light of the COVID-19 crisis. One industry expert, however, observed a level of resilience in the responses from sponsors and research sites and predicted research will pick up quickly after the crisis is over.
Watch the webinar to see Rachel Truxall, corporate director of business development at Insearch Group, discuss her post-COVID predictions and her reasoning behind them. She also offers advice, including how to maintain regular communication with sponsors and CROs to preserve patient safety, as well as to how to think of creative ways of generating revenue or participating in studies (e.g., by partnering with other sites).